Compass Therapeutics
Price & Volume
Stats
See more52W Range | $1.33-$5.84 |
Market Cap | $958.6M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.45 |
News
See moreYahoo Finance • 5 days ago
Compass Therapeutics to Participate in Upcoming December Investor Events
Yahoo Finance • 12 days ago
Compass Therapeutics Inc. (CMPX) is A Buy on Wall Street on Robust Pipeline Development
Yahoo Finance • 12 days ago
Eli Lilly inks $2.6B deal with South Korea's ABL Bio for bispecific antibodies
Yahoo Finance • 25 days ago
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Dr. Thomas J. Schuetz M.D., Ph.D. |
Address | 80 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 35 |
